Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment

28 May 1999

Abstract excerpt

Neuroblastoma is one of the most common malignant tumors of childhood and is characterized by regressive and progressive disease. Genetic factors that define progression of neuroblastomas are still unknown. We performed comparative genomic hybridization (CGH) on 27 neuroblastomas and dual-color fluorescence in situ hybridization (FISH) to identify genetic aberrations associated with progressive neuroblastoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10379872
DOI: 10.1002/(sici)1098-2264(199907)25:3<261::aid-gcc8>3.0.co;2-#

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatmentPMID 10379872Read ↗

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.Semantic proximity Read ↗

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridizationSemantic proximity Read ↗

Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaSemantic proximity Read ↗

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.Semantic proximity Read ↗

Neuroblastoma: Effect of genetic factors on prognosis and treatmentSemantic proximity Read ↗

Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.Semantic proximity Read ↗

Oligonucleotide array‐based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcomeSemantic proximity Read ↗

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patientsSemantic proximity Read ↗

Molecular cytogenetic characterization of two non-MYCN amplified neuroblastoma cell lines with complex t(11;17).Semantic proximity Read ↗

17q gain in neuroblastoma predicts adverse clinical outcomeSemantic proximity Read ↗

Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplificationSemantic proximity Read ↗

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.